|
Markt geschlossen -
Nasdaq Stockholm
18:00:00 09.10.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 1’591.50 SEK | +1.08% |
|
+1.11% | -6.57% |
| 09.10. | INTERVIEW/Astrazeneca-Sparte Biopharmaceuticals sieht kräftiges Wachstum | DJ |
| 09.10. | Daiichi Sankyo und AstraZenecas Datroway erhalten in China Zulassung für zweite Brustkrebs-Indikation | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.83% | +3.19% | +4.90% | -3.10% | +9.73% | +37.87% | +106.25% | +404.09% | +1’336.56% | 1’051 Mrd. | |
| +1.93% | +2.11% | -2.11% | +0.90% | +26.33% | +36.82% | +64.90% | +62.46% | +119.26% | 630 Mrd. | |
| +1.49% | +5.19% | +10.19% | +10.63% | +21.00% | +19.84% | +85.41% | +148.67% | +339.33% | 489 Mrd. | |
| +2.26% | +0.90% | -1.31% | +16.41% | +38.32% | +66.40% | +39.33% | +80.58% | +131.96% | 359 Mrd. | |
| +1.45% | +3.50% | +2.90% | +6.65% | +9.02% | +21.87% | +42.64% | -0.78% | +50.15% | 344 Mrd. | |
| +1.17% | +2.37% | +6.66% | -4.18% | +8.67% | +11.71% | +35.14% | +55.48% | +55.58% | 272 Mrd. | |
| +0.89% | +1.08% | +2.99% | -10.15% | -12.99% | -7.28% | +10.52% | +34.98% | +135.90% | 246 Mrd. | |
| +1.82% | +2.94% | +6.03% | +14.09% | +26.75% | +40.43% | +52.78% | +98.55% | +147.68% | 224 Mrd. | |
| +2.77% | +4.44% | +3.79% | +12.11% | +23.16% | +29.49% | +101.40% | +122.15% | +100.92% | 187 Mrd. | |
| +2.14% | +2.61% | -11.65% | -20.27% | -21.52% | -32.76% | -60.12% | -19.25% | +88.86% | 169 Mrd. | |
| +1.65% | +1.73% | +1.80% | +16.62% | +13.57% | +12.04% | -14.82% | -33.38% | -15.73% | 161 Mrd. | |
| +1.36% | +1.06% | -2.12% | +2.74% | +12.51% | +22.95% | +43.60% | +185.06% | +495.19% | 129 Mrd. | |
| -0.77% | -3.32% | -8.21% | +2.04% | +9.60% | +32.32% | +4.43% | +3.25% | +6.66% | 121 Mrd. | |
| +0.92% | +4.05% | +5.29% | +18.42% | +14.45% | +23.86% | +107.81% | +368.95% | +466.18% | 109 Mrd. | |
| +0.83% | +1.00% | -3.66% | -6.49% | -13.54% | -15.68% | -30.28% | -15.16% | +3.95% | 95.94 Mrd. | |
| +0.84% | -1.66% | -2.97% | -10.69% | -4.08% | +6.71% | +16.03% | +0.07% | -18.08% | 92.79 Mrd. | |
| +14.21% | +18.41% | +65.92% | +193.89% | +662.97% | +717.29% | +120.93% | -26.21% | - | 89.83 Mrd. | |
| +0.94% | +1.54% | -7.57% | +11.77% | -3.28% | +30.99% | -10.25% | +35.73% | +91.39% | 74.55 Mrd. | |
| +1.58% | +0.69% | +3.88% | -1.25% | +12.44% | +16.67% | -11.09% | -26.07% | +43.41% | 67.11 Mrd. | |
| Durchschnitt | +2.02% | +2.57% | +3.93% | +13.16% | +43.85% | +56.40% | +37.09% | +77.85% | +198.84% | 258.62 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +1.63% | +2.43% | +3.37% | +6.30% | +25.40% | +39.27% | +56.88% | +139.88% | +403.81% |
- Börse
- Aktien
- 886455 Aktie
- 886455 Aktie
- Sektor AstraZeneca PLC
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
